1-(6-Fluoropyridin-2-yl)-4-methylpiperazine

Catalog No. :
ACWKFN150
CAS No. :
1248380-56-4
Molecular Formula :
C10H14FN3
Molecular Weight :
195.24

IUPAC Name:1-(6-fluoropyridin-2-yl)-4-methylpiperazine

1-(6-Fluoropyridin-2-yl)-4-methylpiperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$69.00Login to see priceInquiryInquiry
1g96%$164.00Login to see priceInquiryInquiry
5g96%$492.00Login to see priceInquiryInquiry
10g96%$819.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(6-Fluoropyridin-2-yl)-4-methylpiperazine
IUPAC Name1-(6-fluoropyridin-2-yl)-4-methylpiperazine
Molecular FormulaC10H14FN3
Molecular Weight195.24
SMILESCN1CCN(CC1)C1=NC(F)=CC=C1
InChI KeyIBVBILROIOPJNE-UHFFFAOYSA-N
Synonym1-(6-Fluoropyridin-2-yl)-4-methylpiperazine;Piperazine, 1-(6-fluoro-2-pyridinyl)-4-methyl-;1-(6-Fluoro-2-pyridinyl)-4-methylpiperazine
CAS No.1248380-56-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWKFN150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACFEQX069 route compound structure diagram
    ACFEQX069144100-07-2 In Stock
  4. Then
  5. ACWKFN150 route product structure diagram
    ACWKFN1501248380-56-4
Inquiry

2. ACWKFN150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACWCUY163 route compound structure diagram
    ACWCUY16320885-12-5 In Stock
  4. Then
  5. ACWKFN150 route product structure diagram
    ACWKFN1501248380-56-4
Inquiry

Comments (0)